Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE DDI sub-study: DP-dolutegravir ART drug-drug interactions in pregnancy
PACTR201910580840196Completed
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dihydroartemisinin + piperaquine, dolutegravir and efavirenz in malaria and human immunodeficiency virus infection (HIV) (2 arms), sponsored by Liverpool School of Tropical Medicine. Primary endpoint: Primary pharmacokinetic endpoint. Started Oct 2019; status: completed.
02
Drugs
dihydroartemisinin + piperaquinedolutegravirefavirenz
03
Conditions
malariahuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR201910580840196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201910580840196.